Evidence map›Paper›PMID 36987176›Full record

ArticlePolymers2023

Fabrication of Solvent-Free PCL/β-TCP Composite Fiber for 3D Printing: Physiochemical and Biological Investigation.

Sin Ting Ngo, Wei-Fang Lee, Yi-Fan Wu, Eisner Salamanca, Lwin Moe Aung, Yan-Qiao Chao, Ting-Chia Tsao, Hao-Wen Hseuh, Yi-Huan Lee, Ching-Chiung Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Sin Ting NgoPh.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
Wei-Fang LeeSchool of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.
Yi-Fan WuSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0001-8872-6014
Eisner SalamancaSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.
Lwin Moe AungSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0002-9680-7719
Yan-Qiao ChaoSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.
Ting-Chia TsaoSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.
Hao-Wen HseuhSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0003-4217-7595
Yi-Huan LeeDepartment of Molecular Science and Engineering, National Taipei University of Technology, Taipei 106, Taiwan.
Ching-Chiung WangPh.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
Wei-Jen ChangSchool of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110, Taiwan.
Taipei Medical University · TWNational Taipei University of Technology · TWTaipei Medical University Hospital · TWTaipei Medical University-Shuang Ho Hospital · TW

Funding

Ministry of Science and Technology MOST 108-2314-B-038-034the University System of Taipei Joint Research Program USTP-NTUT-TMU-109-07
6 · The paper itself

Abstract

Manufacturing three-dimensional (3D) objects with polymers/bioceramic composite materials has been investigated in recent years. In this study, we manufactured and evaluated solvent-free polycaprolactone (PCL) and beta-tricalcium phosphate (β-TCP) composite fiber as a scaffold material for 3D printing. To investigate the optimal ratio of feedstock material for 3D printing, the physical and biological characteristics of four different ratios of β-TCP compounds mixed with PCL were investigated. PCL/β-TCP ratios of 0 wt.%, 10 wt.%, 20 wt.%, and 30 wt.% were fabricated, with PCL melted at 65 °C and blended with β-TCP with no solvent added during the fabrication process. Electron microscopy revealed an even distribution of β-TCP in the PCL fibers, while Fourier transform infrared spectroscopy demonstrated that the biomaterial compounds remained intact after the heating and manufacturing process. In addition, adding 20% β-TCP into the PCL/β-TCP mixture significantly increased hardness and Young's Modulus by 10% and 26.5%, respectively, suggesting that PCL-20 has better resistance to deformation under load. Cell viability, alkaline phosphatase (ALPase) activity, osteogenic gene expression, and mineralization were also observed to increase according to the amount of β-TCP added. Cell viability and ALPase activity were 20% higher with PCL-30, while upregulation for osteoblast-related gene expression was better with PCL-20. In conclusion, PCL-20 and PCL-30 fibers fabricated without solvent exhibited excellent mechanical properties, high biocompatibility, and high osteogenic ability, making them promising materials for 3D printing customized bone scaffolds promptly, sustainably, and cost-effectively.

Indexed as

3D printingbeta-tricalcium phosphate (β-TCP)guided-bone regenerationpolycaprolactone (PCL)solvent-free

Identifiers

PMID36987176
PMCPMC10053981
OpenAlexW4324088967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.